Potential partners would have been in the Data Room for months now. This presentation is for brokers and clients.
For the money NEU are chasing, a huge team of experts in several fields would have forensically studied every detail.
NEU with its 5 orphan drug tickets and the opportunity to chase the broader Autism market(plus several more diseases) is a very rare beast.
Ann: Neuren Corporate Presentation, October 2019, page-22
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.90 |
Change
0.290(2.13%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $2.583M | 186.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33 | $13.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.90 | 234 | 11 |
View Market Depth
| Last trade - 14.49pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |